{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:20:49Z","timestamp":1793326849635,"version":"4.5.0"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Obes Rep"],"DOI":"10.1007\/s13679-025-00626-y","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T14:59:53Z","timestamp":1744642793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Understanding the Link Between Sterol Regulatory Element Binding Protein (SREBPs) and Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7483-0857","authenticated-orcid":false,"given":"Pervej Alom","family":"Barbhuiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3992-1117","authenticated-orcid":false,"given":"Ren","family":"Yoshitomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manash Pratim","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"key":"626_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41419-024-06774-8","volume":"15","author":"A Eirin","year":"2024","unstructured":"Eirin A, Thaler R, Glasstetter LM, Xing L, Zhu X-Y, Osborne AC, et al. Obesity-driven mitochondrial dysfunction in human adipose tissue-derived mesenchymal stem\/stromal cells involves epigenetic changes. Cell Death Dis. 2024;15:387.","journal-title":"Cell Death Dis"},{"key":"626_CR2","doi-asserted-by":"publisher","unstructured":"Barbhuiya PA, Sen S, Pathak MP. Ameliorative role of bioactive phytoconstituents targeting obesity associated NAFLD by modulation of inflammation and lipogenesis pathways: a comprehensive review. Phytochem Rev [Internet]. 2023 [cited 2024 Feb 7]; Available from: https:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s11101-023-09912-w","DOI":"10.1007\/s11101-023-09912-w"},{"key":"626_CR3","doi-asserted-by":"crossref","unstructured":"Pathak MP, Patowary P, Chattopadhyay P, Barbhuiyan PA, Islam J, Gogoi J, et al. Obesity-associated Airway Hyperresponsiveness: Mechanisms Underlying Inflammatory Markers and Possible Pharmacological Interventions. Endocr Metab Immune Disord - Drug Targets [Internet]. 2023 [cited 2023 Nov 27];24. Available from: https:\/\/www.eurekaselect.com\/223503\/article","DOI":"10.2174\/0118715303256440231028072049"},{"key":"626_CR4","unstructured":"Putra IGNE, Daly M, Sutin A, Steptoe A, Scholes S, Robinson E. Obesity, psychological well-being related measures, and risk of seven non-communicable diseases: evidence from longitudinal studies of UK and US older adults. Int J Obes [Internet]. 2024 [cited 2024 Jun 3]; Available from: https:\/\/www.nature.com\/articles\/s41366-024-01551-1"},{"key":"626_CR5","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/obr.12407","volume":"17","author":"L Li","year":"2016","unstructured":"Li L, Liu D-W, Yan H-Y, Wang Z-Y, Zhao S-H, Wang B. Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies: Obesity and non-alcoholic fatty liver disease. Obes Rev. 2016;17:510\u20139.","journal-title":"Obes Rev"},{"key":"626_CR6","doi-asserted-by":"crossref","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS. Adipose tissue, obesity and non-alcoholic fatty liver disease. Minerva Endocrinol [Internet]. 2017 [cited 2023 Jul 5];42. Available from: https:\/\/www.minervamedica.it\/index2.php?show=R07Y2017N02A0092","DOI":"10.23736\/S0391-1977.16.02563-3"},{"key":"626_CR7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73:202\u20139.","journal-title":"J Hepatol"},{"key":"626_CR8","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","volume":"14","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sarin SK, Wong VW-S, Fan J-G, Kawaguchi T, Ahn SH, et al. The Asian pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int. 2020;14:889\u2013919.","journal-title":"Hepatol Int."},{"key":"626_CR9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.14218\/JCTH.2021.00178","volume":"10","author":"E Kaya","year":"2022","unstructured":"Kaya E, Yilmaz Y. Metabolic-associated fatty liver disease (MAFLD): A multi-systemic disease beyond the liver. J Clin Transl Hepatol. 2022;10:329\u201338.","journal-title":"J Clin Transl Hepatol"},{"key":"626_CR10","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s12072-023-10543-8","volume":"17","author":"X-D Zhou","year":"2023","unstructured":"Zhou X-D, Targher G, Byrne CD, Somers V, Kim SU, Chahal CAA, et al. An international multidisciplinary consensus statement on MAFLD and the risk of CVD. Hepatol Int. 2023;17:773\u201391.","journal-title":"Hepatol Int"},{"key":"626_CR11","doi-asserted-by":"publisher","first-page":"15489","DOI":"10.3390\/ijms232415489","volume":"23","author":"X Guo","year":"2022","unstructured":"Guo X, Yin X, Liu Z, Wang J. Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment. Int J Mol Sci. 2022;23:15489.","journal-title":"Int J Mol Sci"},{"key":"626_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s13668-024-00598-w","volume":"14","author":"PA Barbhuiya","year":"2025","unstructured":"Barbhuiya PA, Ahmed A, Dutta PP, Sen S, Pathak MP. Mitigating metabolic dysfunction-associated steatotic liver disease (MASLD): The role of bioactive phytoconstituents in Indian culinary spices. Curr Nutr Rep. 2025;14:20.","journal-title":"Curr Nutr Rep"},{"key":"626_CR13","doi-asserted-by":"publisher","first-page":"101133","DOI":"10.1016\/j.aohep.2023.101133","volume":"29","author":"ME Rinella","year":"2024","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Ann Hepatol. 2024;29:101133.","journal-title":"Ann Hepatol"},{"key":"626_CR14","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1016\/j.jhep.2023.07.021","volume":"80","author":"SJ Song","year":"2024","unstructured":"Song SJ, Lai JCT, Wong GLH, Wong VWS, Yip TCF. Can we use old NAFLD data under the new MASLD definition? J Hepatol. 2024;80:e54-6.","journal-title":"J Hepatol."},{"key":"626_CR15","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/liv.15856","volume":"44","author":"R Song","year":"2024","unstructured":"Song R, Li Z, Zhang Y, Tan J, Chen Z. Comparison of NAFLD, MAFLD and MASLD characteristics and mortality outcomes in United States adults. Liver Int. 2024;44:1051\u201360.","journal-title":"Liver Int"},{"key":"626_CR16","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1016\/j.jhep.2023.08.026","volume":"80","author":"H Hagstr\u00f6m","year":"2024","unstructured":"Hagstr\u00f6m H, Vessby J, Ekstedt M, Shang Y. 99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical. J Hepatol. 2024;80:e76\u20137.","journal-title":"J Hepatol"},{"key":"626_CR17","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jhep.2024.01.014","volume":"80","author":"ZM Younossi","year":"2024","unstructured":"Younossi ZM, Paik JM, Stepanova M, Ong J, Alqahtani S, Henry L. Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease. J Hepatol. 2024;80:694\u2013701.","journal-title":"J Hepatol"},{"key":"626_CR18","doi-asserted-by":"publisher","first-page":"110024","DOI":"10.1016\/j.abb.2024.110024","volume":"757","author":"J Long","year":"2024","unstructured":"Long J, Xu Y, Zhang X, Wu B, Wang C. Role of FXR in the development of NAFLD and intervention strategies of small molecules. Arch Biochem Biophys. 2024;757:110024.","journal-title":"Arch Biochem Biophys"},{"key":"626_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cld.2017.08.003","volume":"22","author":"CC Lindenmeyer","year":"2018","unstructured":"Lindenmeyer CC, McCullough AJ. The natural history of nonalcoholic fatty liver disease-an evolving view. Clin Liver Dis. 2018;22:11\u201321.","journal-title":"Clin Liver Dis"},{"key":"626_CR20","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.drudis.2007.07.009","volume":"12","author":"MH Ahmed","year":"2007","unstructured":"Ahmed MH, Byrne CD. Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD). Drug Discov Today. 2007;12:740\u20137.","journal-title":"Drug Discov Today"},{"key":"626_CR21","doi-asserted-by":"publisher","first-page":"6603522","DOI":"10.1155\/2023\/6603522","volume":"2023","author":"Z Gong","year":"2023","unstructured":"Gong Z, Han S, Li C, Meng T, Huo Y, Liu X, et al. Rhinacanthin C ameliorates insulin resistance and lipid accumulation in NAFLD mice via the AMPK\/SIRT1 and SREBP-1c\/FAS\/ACC signaling pathways. Evid-Based Complement Altern Med ECAM. 2023;2023:6603522.","journal-title":"Evid-Based Complement Altern Med ECAM"},{"key":"626_CR22","first-page":"1073","volume":"8","author":"X Ni","year":"2016","unstructured":"Ni X, Wang H. Silymarin attenuated hepatic steatosis through regulation of lipid metabolism and oxidative stress in a mouse model of nonalcoholic fatty liver disease (NAFLD). Am J Transl Res. 2016;8:1073\u201381.","journal-title":"Am J Transl Res"},{"key":"626_CR23","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.nut.2013.11.016","volume":"30","author":"JMO Andrade","year":"2014","unstructured":"Andrade JMO, Para\u00edso AF, De Oliveira MVM, Martins AME, Neto JF, Guimar\u00e3es ALS, et al. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation. Nutrition. 2014;30:915\u20139.","journal-title":"Nutrition"},{"key":"626_CR24","doi-asserted-by":"publisher","first-page":"096032712211467","DOI":"10.1177\/09603271221146780","volume":"42","author":"L Zhao","year":"2023","unstructured":"Zhao L, Yang L, Ahmad K. Kaempferol ameliorates palmitate-induced lipid accumulation in HepG2 cells through activation of the Nrf2 signaling pathway. Hum Exp Toxicol. 2023;42:096032712211467.","journal-title":"Hum Exp Toxicol"},{"key":"626_CR25","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/mnfr.201400913","volume":"59","author":"S Pisonero-Vaquero","year":"2015","unstructured":"Pisonero-Vaquero S, Mart\u00ednez-Ferreras \u00c1, Garc\u00eda-Mediavilla MV, Mart\u00ednez-Fl\u00f3rez S, Fern\u00e1ndez A, Benet M, et al. Quercetin ameliorates dysregulation of lipid metabolism genes via the PI3K\/AKT pathway in a diet-induced mouse model of nonalcoholic fatty liver disease. Mol Nutr Food Res. 2015;59:879\u201393.","journal-title":"Mol Nutr Food Res"},{"key":"626_CR26","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1248\/bpb.b14-00281","volume":"37","author":"HK Jo","year":"2014","unstructured":"Jo HK, Kim GW, Jeong KJ, Kim DY, Chung SH. Eugenol ameliorates hepatic steatosis and fibrosis by down-regulating SREBP1 gene expression via AMPK-mTOR-p70S6K signaling pathway. Biol Pharm Bull. 2014;37:1341\u201351.","journal-title":"Biol Pharm Bull"},{"key":"626_CR27","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/bcpt.12076","volume":"113","author":"MY Um","year":"2013","unstructured":"Um MY, Hwang KH, Ahn J, Ha TY. Curcumin attenuates diet-induced hepatic steatosis by activating amp -activated protein kinase. Basic Clin Pharmacol Toxicol. 2013;113:152\u20137.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"626_CR28","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.biopha.2017.10.125","volume":"96","author":"J Lu","year":"2017","unstructured":"Lu J, Cheng B, Fang B, Meng Z, Zheng Y, Tian X, et al. Protective effects of allicin on 1,3-DCP-induced lipid metabolism disorder in HepG2 cells. Biomed Pharmacother Biomedecine Pharmacother. 2017;96:1411\u20137.","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"key":"626_CR29","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0092-8674(00)80213-5","volume":"89","author":"MS Brown","year":"1997","unstructured":"Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 1997;89:331\u201340.","journal-title":"Cell"},{"key":"626_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2005.12.022","volume":"124","author":"JL Goldstein","year":"2006","unstructured":"Goldstein JL, DeBose-Boyd RA, Brown MS. Protein sensors for membrane sterols. Cell. 2006;124:35\u201346.","journal-title":"Cell"},{"key":"626_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.abb.2010.06.004","volume":"501","author":"R Sato","year":"2010","unstructured":"Sato R. Sterol metabolism and SREBP activation. Arch Biochem Biophys. 2010;501:177\u201381.","journal-title":"Arch Biochem Biophys"},{"key":"626_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tem.2011.10.004","volume":"23","author":"T-I Jeon","year":"2012","unstructured":"Jeon T-I, Osborne TF. SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol Metab TEM. 2012;23:65\u201372.","journal-title":"Trends Endocrinol Metab TEM"},{"key":"626_CR33","doi-asserted-by":"publisher","first-page":"e25015","DOI":"10.7554\/eLife.25015","volume":"6","author":"S Rong","year":"2017","unstructured":"Rong S, Cort\u00e9s VA, Rashid S, Anderson NN, McDonald JG, Liang G, et al. Expression of SREBP-1c Requires SREBP-2-mediated Generation of a Sterol Ligand for LXR in Livers of Mice. eLife. 2017;6:e25015.","journal-title":"eLife."},{"key":"626_CR34","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nrendo.2017.91","volume":"13","author":"H Shimano","year":"2017","unstructured":"Shimano H, Sato R. SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology. Nat Rev Endocrinol. 2017;13:710\u201330.","journal-title":"Nat Rev Endocrinol"},{"key":"626_CR35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.31083\/j.jin2103095","volume":"21","author":"MJ Ang","year":"2022","unstructured":"Ang MJ, Moon C. SREBP and central nervous system disorders: genetic overlaps revealed by in silico analysis. J Integr Neurosci. 2022;21:95.","journal-title":"J Integr Neurosci"},{"key":"626_CR36","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S1097-2765(02)00591-9","volume":"10","author":"AJ Brown","year":"2002","unstructured":"Brown AJ, Sun L, Feramisco JD, Brown MS, Goldstein JL. Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism. Mol Cell. 2002;10:237\u201345.","journal-title":"Mol Cell"},{"key":"626_CR37","doi-asserted-by":"publisher","first-page":"11694","DOI":"10.1073\/pnas.182412799","volume":"99","author":"PJ Espenshade","year":"2002","unstructured":"Espenshade PJ, Li W-P, Yabe D. Sterols block binding of COPII proteins to SCAP, thereby controlling SCAP sorting in ER. Proc Natl Acad Sci U S A. 2002;99:11694\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"626_CR38","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s12276-020-0430-0","volume":"52","author":"SH Lee","year":"2020","unstructured":"Lee SH, Lee J-H, Im S-S. The cellular function of SCAP in metabolic signaling. Exp Mol Med. 2020;52:724\u20139.","journal-title":"Exp Mol Med"},{"key":"626_CR39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cmet.2005.11.014","volume":"3","author":"Y Gong","year":"2006","unstructured":"Gong Y, Lee JN, Lee PCW, Goldstein JL, Brown MS, Ye J. Sterol-regulated ubiquitination and degradation of Insig-1 creates a convergent mechanism for feedback control of cholesterol synthesis and uptake. Cell Metab. 2006;3:15\u201324.","journal-title":"Cell Metab"},{"key":"626_CR40","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1055\/s-0033-1358523","volume":"33","author":"X Xu","year":"2013","unstructured":"Xu X, So J-S, Park J-G, Lee A-H. Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP. Semin Liver Dis. 2013;33:301\u201311.","journal-title":"Semin Liver Dis"},{"key":"626_CR41","doi-asserted-by":"publisher","first-page":"eabb2224","DOI":"10.1126\/science.abb2224","volume":"371","author":"R Yan","year":"2021","unstructured":"Yan R, Cao P, Song W, Qian H, Du X, Coates HW, et al. A structure of human Scap bound to Insig-2 suggests how their interaction is regulated by sterols. Science. 2021;371:eabb2224.","journal-title":"Science."},{"key":"626_CR42","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s42255-022-00568-y","volume":"4","author":"C Cheng","year":"2022","unstructured":"Cheng C, Geng F, Li Z, Zhong Y, Wang H, Cheng X, et al. Ammonia stimulates SCAP\/Insig dissociation and SREBP-1 activation to promote lipogenesis and tumour growth. Nat Metab. 2022;4:575\u201388.","journal-title":"Nat Metab"},{"key":"626_CR43","doi-asserted-by":"publisher","first-page":"6465","DOI":"10.1038\/sj.onc.1208802","volume":"24","author":"T Porstmann","year":"2005","unstructured":"Porstmann T, Griffiths B, Chung Y-L, Delpuech O, Griffiths JR, Downward J, et al. PKB\/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP. Oncogene. 2005;24:6465\u201381.","journal-title":"Oncogene"},{"key":"626_CR44","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1158\/2159-8290.CD-11-0102","volume":"1","author":"D Guo","year":"2011","unstructured":"Guo D, Reinitz F, Youssef M, Hong C, Nathanson D, Akhavan D, et al. An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR\/AKT\/SREBP-1\/LDLR\u2013dependent pathway. Cancer Discov. 2011;1:442\u201356.","journal-title":"Cancer Discov"},{"key":"626_CR45","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.immuni.2018.08.021","volume":"49","author":"C Guo","year":"2018","unstructured":"Guo C, Chi Z, Jiang D, Xu T, Yu W, Wang Z, et al. Cholesterol homeostatic regulator SCAP-SREBP2 integrates NLRP3 inflammasome activation and cholesterol biosynthetic signaling in macrophages. Immunity. 2018;49:842-856.e7.","journal-title":"Immunity"},{"key":"626_CR46","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cmet.2010.12.004","volume":"13","author":"J-J Tang","year":"2011","unstructured":"Tang J-J, Li J-G, Qi W, Qiu W-W, Li P-S, Li B-L, et al. Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques. Cell Metab. 2011;13:44\u201356.","journal-title":"Cell Metab"},{"key":"626_CR47","doi-asserted-by":"publisher","first-page":"153610","DOI":"10.1016\/j.phymed.2021.153610","volume":"89","author":"MP Pathak","year":"2021","unstructured":"Pathak MP, Patowary P, Goyary D, Das A, Chattopadhyay P. \u03b2-caryophyllene ameliorated obesity-associated airway hyperresponsiveness through some non-conventional targets. Phytomedicine. 2021;89:153610.","journal-title":"Phytomedicine"},{"key":"626_CR48","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.cmet.2016.11.009","volume":"25","author":"Y Oishi","year":"2017","unstructured":"Oishi Y, Spann NJ, Link VM, Muse ED, Strid T, Edillor C, et al. SREBP1 contributes to resolution of pro-inflammatory TLR4 signaling by reprogramming fatty acid metabolism. Cell Metab. 2017;25:412\u201327.","journal-title":"Cell Metab"},{"key":"626_CR49","doi-asserted-by":"publisher","first-page":"6232","DOI":"10.1074\/jbc.M116.713818","volume":"291","author":"L-H Huang","year":"2016","unstructured":"Huang L-H, Melton EM, Li H, Sohn P, Rogers MA, Mulligan-Kehoe MJ, et al. Myeloid Acyl-CoA: Cholesterol acyltransferase 1 deficiency reduces lesion macrophage content and suppresses atherosclerosis progression. J Biol Chem. 2016;291:6232\u201344.","journal-title":"J Biol Chem"},{"key":"626_CR50","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","volume":"56","author":"S Mottillo","year":"2010","unstructured":"Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk. J Am Coll Cardiol. 2010;56:1113\u201332.","journal-title":"J Am Coll Cardiol"},{"key":"626_CR51","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jocn.2017.01.018","volume":"40","author":"X Li","year":"2017","unstructured":"Li X, Li X, Lin H, Fu X, Lin W, Li M, et al. Metabolic syndrome and stroke: A meta-analysis of prospective cohort studies. J Clin Neurosci. 2017;40:34\u20138.","journal-title":"J Clin Neurosci"},{"key":"626_CR52","doi-asserted-by":"crossref","unstructured":"Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539\u201353.","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S"},{"key":"626_CR53","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1046\/j.1464-5491.1999.00059.x","volume":"16","author":"B Balkau","year":"1999","unstructured":"Balkau B, Charles M. Comment on the provisional report from the WHO consultation. Diabet Med. 1999;16:442\u20133.","journal-title":"Diabet Med"},{"key":"626_CR54","doi-asserted-by":"crossref","unstructured":"Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J Am Med Assoc. 2001;285:2486\u201397.","DOI":"10.1001\/jama.285.19.2486"},{"key":"626_CR55","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","volume":"20","author":"MG Saklayen","year":"2018","unstructured":"Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20:12.","journal-title":"Curr Hypertens Rep"},{"key":"626_CR56","doi-asserted-by":"publisher","first-page":"382","DOI":"10.5551\/jat.64380","volume":"31","author":"Y Yamazaki","year":"2024","unstructured":"Yamazaki Y, Fujihara K, Sato T, Harada Yamada M, Yaguchi Y, Matsubayashi Y, et al. Usefulness of new criteria for metabolic syndrome optimized for prediction of cardiovascular diseases in Japanese. J Atheroscler Thromb. 2024;31:382\u201395.","journal-title":"J Atheroscler Thromb"},{"key":"626_CR57","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1172\/JCI0215593","volume":"109","author":"JD Horton","year":"2002","unstructured":"Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002;109:1125\u201331.","journal-title":"J Clin Invest"},{"key":"626_CR58","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/oby.2001.95","volume":"9","author":"M Kolehmainen","year":"2001","unstructured":"Kolehmainen M, Vidal H, Alhava E, Uusitupa MIJ. Sterol regulatory element binding protein 1c (SREBP-1c) expression in human obesity. Obes Res. 2001;9:706\u201312.","journal-title":"Obes Res"},{"key":"626_CR59","doi-asserted-by":"publisher","first-page":"E90","DOI":"10.1152\/ajpendo.00543.2005","volume":"291","author":"KJ Nadeau","year":"2006","unstructured":"Nadeau KJ, Ehlers LB, Aguirre LE, Moore RL, Jew KN, Ortmeyer HK, et al. Exercise training and calorie restriction increase SREBP-1 expression and intramuscular triglyceride in skeletal muscle. Am J Physiol-Endocrinol Metab. 2006;291:E90\u20138.","journal-title":"Am J Physiol-Endocrinol Metab"},{"key":"626_CR60","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/nature05482","volume":"444","author":"SE Kahn","year":"2006","unstructured":"Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444:840\u20136.","journal-title":"Nature"},{"key":"626_CR61","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11892-018-1101-6","volume":"18","author":"P Bjornstad","year":"2018","unstructured":"Bjornstad P, Eckel RH. Pathogenesis of lipid disorders in insulin resistance: A brief review. Curr Diab Rep. 2018;18:127.","journal-title":"Curr Diab Rep"},{"key":"626_CR62","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1097-2765(05)00010-9","volume":"6","author":"I Shimomura","year":"2000","unstructured":"Shimomura I, Matsuda M, Hammer RE, Bashmakov Y, Brown MS, Goldstein JL. Decreased IRS-2 and Increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob\/ob mice. Mol Cell. 2000;6:77\u201386.","journal-title":"Mol Cell"},{"key":"626_CR63","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4093\/dmj.2021.0280","volume":"46","author":"S-H Lee","year":"2022","unstructured":"Lee S-H, Park S-Y, Choi CS. Insulin resistance: From mechanisms to therapeutic strategies. Diabetes Metab J. 2022;46:15\u201337.","journal-title":"Diabetes Metab J"},{"key":"626_CR64","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1172\/JCI119248","volume":"99","author":"H Shimano","year":"1997","unstructured":"Shimano H, Horton JD, Shimomura I, Hammer RE, Brown MS, Goldstein JL. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J Clin Invest. 1997;99:846\u201354.","journal-title":"J Clin Invest"},{"key":"626_CR65","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1101\/gad.10.9.1096","volume":"10","author":"JB Kim","year":"1996","unstructured":"Kim JB, Spiegelman BM. ADD1\/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev. 1996;10:1096\u2013107.","journal-title":"Genes Dev"},{"key":"626_CR66","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.2174\/13816128113199990486","volume":"20","author":"D Guo","year":"2014","unstructured":"Guo D, Bell E, Mischel P, Chakravarti A. Targeting SREBP-1-driven lipid metabolism to treat cancer. Curr Pharm Des. 2014;20:2619\u201326.","journal-title":"Curr Pharm Des"},{"key":"626_CR67","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1161\/01.ATV.0000183883.72263.13","volume":"25","author":"T Suganami","year":"2005","unstructured":"Suganami T, Nishida J, Ogawa Y. A Paracrine loop between adipocytes and macrophages aggravates inflammatory changes: Role of free fatty acids and tumor necrosis factor \u03b1. Arterioscler Thromb Vasc Biol. 2005;25:2062\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"626_CR68","doi-asserted-by":"publisher","first-page":"12228","DOI":"10.1073\/pnas.1005191107","volume":"107","author":"TJ Marquart","year":"2010","unstructured":"Marquart TJ, Allen RM, Ory DS, Bald\u00e1n \u00c1. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci. 2010;107:12228\u201332.","journal-title":"Proc Natl Acad Sci"},{"key":"626_CR69","doi-asserted-by":"publisher","first-page":"17321","DOI":"10.1073\/pnas.1008499107","volume":"107","author":"T Horie","year":"2010","unstructured":"Horie T, Ono K, Horiguchi M, Nishi H, Nakamura T, Nagao K, et al. MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 ( Srebp2) regulates HDL in vivo. Proc Natl Acad Sci. 2010;107:17321\u20136.","journal-title":"Proc Natl Acad Sci"},{"key":"626_CR70","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.2337\/diabetes.53.8.2153","volume":"53","author":"D Eberl\u00e9","year":"2004","unstructured":"Eberl\u00e9 D, Cl\u00e9ment K, Meyre D, Sahbatou M, Vaxillaire M, Le Gall A, et al. SREBF-1 gene polymorphisms are associated with obesity and type 2 diabetes in French obese and diabetic cohorts. Diabetes. 2004;53:2153\u20137.","journal-title":"Diabetes"},{"key":"626_CR71","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","volume":"13","author":"Y Li","year":"2011","unstructured":"Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, et al. AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice. Cell Metab. 2011;13:376\u201388.","journal-title":"Cell Metab"},{"key":"626_CR72","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s00535-013-0758-5","volume":"48","author":"Y Kawano","year":"2013","unstructured":"Kawano Y, Cohen DE. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. J Gastroenterol. 2013;48:434\u201341.","journal-title":"J Gastroenterol"},{"key":"626_CR73","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","volume":"146","author":"JE Lambert","year":"2014","unstructured":"Lambert JE, Ramos-Roman MA, Browning JD, Parks EJ. Increased De Novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology. 2014;146:726\u201335.","journal-title":"Gastroenterology"},{"key":"626_CR74","doi-asserted-by":"publisher","first-page":"9520","DOI":"10.1074\/jbc.M111421200","volume":"277","author":"G Liang","year":"2002","unstructured":"Liang G, Yang J, Horton JD, Hammer RE, Goldstein JL, Brown MS. Diminished hepatic response to fasting\/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J Biol Chem. 2002;277:9520\u20138.","journal-title":"J Biol Chem"},{"key":"626_CR75","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0014-4827(02)00023-X","volume":"282","author":"YA Yang","year":"2003","unstructured":"Yang YA, Morin PJ, Han WF, Chen T, Bornman DM, Gabrielson EW, et al. Regulation of fatty acid synthase expression in breast cancer by sterol regulatory element binding protein-1c. Exp Cell Res. 2003;282:132\u20137.","journal-title":"Exp Cell Res."},{"key":"626_CR76","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/brv.12178","volume":"91","author":"FWB Sanders","year":"2016","unstructured":"Sanders FWB, Griffin JL. De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose. Biol Rev Camb Philos Soc. 2016;91:452\u201368.","journal-title":"Biol Rev Camb Philos Soc"},{"key":"626_CR77","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3109\/10409231003667500","volume":"45","author":"MS Strable","year":"2010","unstructured":"Strable MS, Ntambi JM. Genetic control of de novo lipogenesis: role in diet-induced obesity. Crit Rev Biochem Mol Biol. 2010;45:199\u2013214.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"626_CR78","doi-asserted-by":"crossref","unstructured":"Imamura F, Fretts AM, Marklund M, Ardisson Korat AV, Yang W-S, Lankinen M, et al. Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies. PLOS Med. 2020;17:e1003102.","DOI":"10.1371\/journal.pmed.1003102"},{"key":"626_CR79","doi-asserted-by":"publisher","first-page":"101185","DOI":"10.1016\/j.jhepr.2024.101185","volume":"6","author":"F Carli","year":"2024","unstructured":"Carli F, Della Pepa G, Sabatini S, Vidal Puig A, Gastaldelli A. Lipid metabolism in MASLD and MASH: From mechanism to the clinic. JHEP Rep. 2024;6:101185.","journal-title":"JHEP Rep"},{"key":"626_CR80","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1194\/jlr.M700033-JLR200","volume":"48","author":"M Sekiya","year":"2007","unstructured":"Sekiya M, Yahagi N, Matsuzaka T, Takeuchi Y, Nakagawa Y, Takahashi H, et al. SREBP-1-independent regulation of lipogenic gene expression in adipocytes. J Lipid Res. 2007;48:1581\u201391.","journal-title":"J Lipid Res"},{"key":"626_CR81","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature10986","volume":"484","author":"MA Herman","year":"2012","unstructured":"Herman MA, Peroni OD, Villoria J, Sch\u00f6n MR, Abumrad NA, Bl\u00fcher M, et al. A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Nature. 2012;484:333\u20138.","journal-title":"Nature"},{"key":"626_CR82","doi-asserted-by":"publisher","first-page":"e129397","DOI":"10.1172\/jci.insight.129397","volume":"4","author":"C Crewe","year":"2019","unstructured":"Crewe C, Zhu Y, Paschoal VA, Joffin N, Ghaben AL, Gordillo R, et al. SREBP-regulated adipocyte lipogenesis is dependent on substrate availability and redox modulation of mTORC1. JCI Insight. 2019;4:e129397.","journal-title":"JCI Insight"},{"key":"626_CR83","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0083-6729(02)65064-2","volume":"65","author":"H Shimano","year":"2002","unstructured":"Shimano H. Sterol regulatory element-binding protein family as global regulators of lipid synthetic genes in energy metabolism. Vitam Horm. 2002;65:167\u201394.","journal-title":"Vitam Horm"},{"key":"626_CR84","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/00041433-199904000-00008","volume":"10","author":"JD Horton","year":"1999","unstructured":"Horton JD, Shimomura I. Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis. Curr Opin Lipidol. 1999;10:143\u201350.","journal-title":"Curr Opin Lipidol"},{"key":"626_CR85","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00109-007-0158-5","volume":"85","author":"H Shimano","year":"2007","unstructured":"Shimano H. SREBP-1c and TFE3, energy transcription factors that regulate hepatic insulin signaling. J Mol Med Berl Ger. 2007;85:437\u201344.","journal-title":"J Mol Med Berl Ger"},{"key":"626_CR86","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/hep.24402","volume":"54","author":"A Qiao","year":"2011","unstructured":"Qiao A, Liang J, Ke Y, Li C, Cui Y, Shen L, et al. Mouse patatin-like phospholipase domain-containing 3 influences systemic lipid and glucose homeostasis. Hepatology. 2011;54:509\u201321.","journal-title":"Hepatology"},{"key":"626_CR87","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1002\/hep.24283","volume":"53","author":"S Sookoian","year":"2011","unstructured":"Sookoian S, Pirola CJ. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatol Baltim Md. 2011;53:1883\u201394.","journal-title":"Hepatol Baltim Md"},{"key":"626_CR88","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1507\/endocrj.K07E-110","volume":"55","author":"K Iizuka","year":"2008","unstructured":"Iizuka K, Horikawa Y. ChREBP: A Glucose-activated Transcription Factor Involved in the Development of Metabolic Syndrome. Endocr J. 2008;55:617\u201324.","journal-title":"Endocr J"},{"key":"626_CR89","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.tem.2013.01.003","volume":"24","author":"G Filhoulaud","year":"2013","unstructured":"Filhoulaud G, Guilmeau S, Dentin R, Girard J, Postic C. Novel insights into ChREBP regulation and function. Trends Endocrinol Metab. 2013;24:257\u201368.","journal-title":"Trends Endocrinol Metab"},{"key":"626_CR90","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1101\/gad.1854309","volume":"23","author":"TF Osborne","year":"2009","unstructured":"Osborne TF, Espenshade PJ. Evolutionary conservation and adaptation in the mechanism that regulates SREBP action: what a long, strange tRIP it\u2019s been. Genes Dev. 2009;23:2578\u201391.","journal-title":"Genes Dev"},{"key":"626_CR91","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cmet.2006.11.012","volume":"5","author":"W Chen","year":"2007","unstructured":"Chen W, Chen G, Head DL, Mangelsdorf DJ, Russell DW. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. Cell Metab. 2007;5:73\u20139.","journal-title":"Cell Metab"},{"key":"626_CR92","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1073\/pnas.0914798107","volume":"107","author":"S Li","year":"2010","unstructured":"Li S, Brown MS, Goldstein JL. Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc Natl Acad Sci U S A. 2010;107:3441\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"626_CR93","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/MOL.0b013e328352dd03","volume":"23","author":"I Bakan","year":"2012","unstructured":"Bakan I, Laplante M. Connecting mTORC1 signaling to SREBP-1 activation. Curr Opin Lipidol. 2012;23:226\u201334.","journal-title":"Curr Opin Lipidol"},{"key":"626_CR94","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1073\/pnas.0405067102","volume":"102","author":"BD Hegarty","year":"2005","unstructured":"Hegarty BD, Bobard A, Hainault I, Ferr\u00e9 P, Bossard P, Foufelle F. Distinct roles of insulin and liver X receptor in the induction and cleavage of sterol regulatory elementbinding protein-1c. Proc Natl Acad Sci. 2005;102:791\u20136.","journal-title":"Proc Natl Acad Sci"},{"key":"626_CR95","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev.nutr.012809.104729","volume":"30","author":"LS Csaki","year":"2010","unstructured":"Csaki LS, Reue K. Lipins: Multifunctional Lipid Metabolism Proteins. Annu Rev Nutr. 2010;30:257\u201372.","journal-title":"Annu Rev Nutr"},{"key":"626_CR96","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.cell.2011.06.034","volume":"146","author":"TR Peterson","year":"2011","unstructured":"Peterson TR, Sengupta SS, Harris TE, Carmack AE, Kang SA, Balderas E, et al. mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell. 2011;146:408\u201320.","journal-title":"Cell"},{"key":"626_CR97","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.tem.2010.01.001","volume":"21","author":"JR Krycer","year":"2010","unstructured":"Krycer JR, Sharpe LJ, Luu W, Brown AJ. The Akt-SREBP nexus: cell signaling meets lipid metabolism. Trends Endocrinol Metab TEM. 2010;21:268\u201376.","journal-title":"Trends Endocrinol Metab TEM"},{"key":"626_CR98","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cmet.2011.06.002","volume":"14","author":"JL Yecies","year":"2011","unstructured":"Yecies JL, Zhang HH, Menon S, Liu S, Yecies D, Lipovsky AI, et al. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab. 2011;14:21\u201332.","journal-title":"Cell Metab"},{"key":"626_CR99","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.tem.2010.08.008","volume":"21","author":"KJ Moore","year":"2010","unstructured":"Moore KJ, Rayner KJ, Su\u00e1rez Y, Fern\u00e1ndez-Hernando C. microRNAs and cholesterol metabolism. Trends Endocrinol Metab. 2010;21:699\u2013706.","journal-title":"Trends Endocrinol Metab"},{"key":"626_CR100","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/MOL.0b013e3283428d9d","volume":"22","author":"C Fern\u00e1ndez-Hernando","year":"2011","unstructured":"Fern\u00e1ndez-Hernando C, Su\u00e1rez Y, Rayner KJ, Moore KJ. MicroRNAs in lipid metabolism. Curr Opin Lipidol. 2011;22:86\u201392.","journal-title":"Curr Opin Lipidol"},{"key":"626_CR101","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bbrc.2018.03.127","volume":"499","author":"M Zhang","year":"2018","unstructured":"Zhang M, Chi X, Qu N, Wang C. Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt\/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis. Biochem Biophys Res Commun. 2018;499:66\u201370.","journal-title":"Biochem Biophys Res Commun"},{"key":"626_CR102","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.bbrc.2019.06.104","volume":"516","author":"Y Sun","year":"2019","unstructured":"Sun Y, Song Y, Liu C, Geng J. LncRNA NEAT1-MicroRNA-140 axis exacerbates nonalcoholic fatty liver through interrupting AMPK\/SREBP-1 signaling. Biochem Biophys Res Commun. 2019;516:584\u201390.","journal-title":"Biochem Biophys Res Commun"},{"key":"626_CR103","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1194\/jlr.RA120000664","volume":"61","author":"M Ma","year":"2020","unstructured":"Ma M, Duan R, Shen L, Liu M, Ji Y, Zhou H, et al. The lncRNA Gm15622 stimulates SREBP-1c expression and hepatic lipid accumulation by sponging the miR-742-3p in mice. J Lipid Res. 2020;61:1052\u201364.","journal-title":"J Lipid Res"},{"key":"626_CR104","doi-asserted-by":"publisher","first-page":"16","DOI":"10.21315\/mjms2018.25.1.3","volume":"25","author":"A Moslehi","year":"2018","unstructured":"Moslehi A, Farahabadi M, Chavoshzadeh SA, Barati A, Ababzadeh S, Mohammadbeigi A. The effect of amygdalin on endoplasmic reticulum (ER) stress induced hepatic steatosis in mice. Malays J Med Sci MJMS. 2018;25:16\u201323.","journal-title":"Malays J Med Sci MJMS"},{"key":"626_CR105","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/j.biocel.2007.05.002","volume":"39","author":"SM Colgan","year":"2007","unstructured":"Colgan SM, Tang D, Werstuck GH, Austin RC. Endoplasmic reticulum stress causes the activation of sterol regulatory element binding protein-2. Int J Biochem Cell Biol. 2007;39:1843\u201351.","journal-title":"Int J Biochem Cell Biol"},{"key":"626_CR106","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1111\/febs.15144","volume":"287","author":"Q Hu","year":"2020","unstructured":"Hu Q, Mao Y, Liu M, Luo R, Jiang R, Guo F. The active nuclear form of SREBP1 amplifies ER stress and autophagy via regulation of PERK. FEBS J. 2020;287:2348\u201366.","journal-title":"FEBS J"},{"key":"626_CR107","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.livres.2019.01.002","volume":"3","author":"X Liu","year":"2019","unstructured":"Liu X, Green RM. Endoplasmic reticulum stress and liver diseases. Liver Res. 2019;3:55\u201364.","journal-title":"Liver Res"},{"key":"626_CR108","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1172\/JCI37007","volume":"119","author":"HL Kammoun","year":"2009","unstructured":"Kammoun HL, Chabanon H, Hainault I, Luquet S, Magnan C, Koike T, et al. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J Clin Invest. 2009;119:1201\u201315.","journal-title":"J Clin Invest"},{"key":"626_CR109","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/labinvest.2014.98","volume":"94","author":"Y-J Choi","year":"2014","unstructured":"Choi Y-J, Shin H-S, Choi HS, Park J-W, Jo I, Oh E-S, et al. Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes. Lab Investig J Tech Methods Pathol. 2014;94:1114\u201325.","journal-title":"Lab Investig J Tech Methods Pathol"},{"key":"626_CR110","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cell.2018.08.020","volume":"175","author":"JY Kim","year":"2018","unstructured":"Kim JY, Garcia-Carbonell R, Yamachika S, Zhao P, Dhar D, Loomba R, et al. ER Stress Drives Lipogenesis and Steatohepatitis via Caspase-2 Activation of S1P. Cell. 2018;175:133-145.e15.","journal-title":"Cell"},{"key":"626_CR111","doi-asserted-by":"publisher","first-page":"841362","DOI":"10.1155\/2012\/841362","volume":"2012","author":"S Basseri","year":"2012","unstructured":"Basseri S, Austin RC. Endoplasmic reticulum stress and lipid metabolism: mechanisms and therapeutic potential. Biochem Res Int. 2012;2012:841362.","journal-title":"Biochem Res Int"},{"key":"626_CR112","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.chembiol.2009.07.007","volume":"16","author":"S Kamisuki","year":"2009","unstructured":"Kamisuki S, Mao Q, Abu-Elheiga L, Gu Z, Kugimiya A, Kwon Y, et al. A small molecule that blocks fat synthesis by inhibiting the activation of SREBP. Chem Biol. 2009;16:882\u201392.","journal-title":"Chem Biol"},{"key":"626_CR113","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1194\/jlr.M069583","volume":"57","author":"W Shao","year":"2016","unstructured":"Shao W, Machamer CE, Espenshade PJ. Fatostatin blocks ER exit of SCAP but inhibits cell growth in a SCAP-independent manner. J Lipid Res. 2016;57:1564\u201373.","journal-title":"J Lipid Res"},{"key":"626_CR114","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.1021\/jm200304y","volume":"54","author":"S Kamisuki","year":"2011","unstructured":"Kamisuki S, Shirakawa T, Kugimiya A, Abu-Elheiga L, Park Choo H-Y, Yamada K, et al. Synthesis and Evaluation of Diarylthiazole Derivatives That Inhibit Activation of Sterol Regulatory Element-Binding Proteins. J Med Chem. 2011;54:4923\u20137.","journal-title":"J Med Chem"},{"key":"626_CR115","doi-asserted-by":"publisher","first-page":"895744","DOI":"10.3389\/fphar.2022.895744","volume":"13","author":"D-B Ma","year":"2022","unstructured":"Ma D-B, Liu X-Y, Jia H, Zhang Y, Jiang Q, Sun H, et al. A Novel Small-Molecule Inhibitor of SREBP-1 Based on Natural Product Monomers Upregulates the Sensitivity of Lung Squamous Cell Carcinoma Cells to Antitumor Drugs. Front Pharmacol. 2022;13:895744.","journal-title":"Front Pharmacol"},{"key":"626_CR116","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41389-018-0076-0","volume":"7","author":"V Brovkovych","year":"2018","unstructured":"Brovkovych V, Izhar Y, Danes JM, Dubrovskyi O, Sakallioglu IT, Morrow LM, et al. Fatostatin induces pro- and anti-apoptotic lipid accumulation in breast cancer. Oncogenesis. 2018;7:66.","journal-title":"Oncogenesis"},{"key":"626_CR117","doi-asserted-by":"publisher","first-page":"52772","DOI":"10.1074\/jbc.M410302200","volume":"279","author":"CM Adams","year":"2004","unstructured":"Adams CM, Reitz J, De Brabander JK, Feramisco JD, Li L, Brown MS, et al. Cholesterol and 25-Hydroxycholesterol Inhibit Activation of SREBPs by Different Mechanisms, Both Involving SCAP and Insigs. J Biol Chem. 2004;279:52772\u201380.","journal-title":"J Biol Chem"},{"key":"626_CR118","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.chembiol.2016.12.017","volume":"24","author":"L Asano","year":"2017","unstructured":"Asano L, Watanabe M, Ryoden Y, Usuda K, Yamaguchi T, Khambu B, et al. Vitamin D Metabolite, 25-Hydroxyvitamin D, Regulates Lipid Metabolism by Inducing Degradation of SREBP\/SCAP. Cell Chem Biol. 2017;24:207\u201317.","journal-title":"Cell Chem Biol"},{"key":"626_CR119","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1039\/D3MD00352C","volume":"14","author":"F Kawagoe","year":"2023","unstructured":"Kawagoe F, Mototani S, Mendoza A, Takemoto Y, Uesugi M, Kittaka A. Structure\u2013activity relationship studies on vitamin D-based selective SREBP\/SCAP inhibitor KK-052. RSC Med Chem. 2023;14:2030\u20134.","journal-title":"RSC Med Chem"},{"key":"626_CR120","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1124\/jpet.108.139626","volume":"326","author":"JL Hawkins","year":"2008","unstructured":"Hawkins JL, Robbins MD, Warren LC, Xia D, Petras SF, Valentine JJ, et al. Pharmacologic Inhibition of Site 1 Protease Activity Inhibits Sterol Regulatory Element-Binding Protein Processing and Reduces Lipogenic Enzyme Gene Expression and Lipid Synthesis in Cultured Cells and Experimental Animals. J Pharmacol Exp Ther. 2008;326:801\u20138.","journal-title":"J Pharmacol Exp Ther"},{"key":"626_CR121","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11010-013-1694-7","volume":"381","author":"D Fang","year":"2013","unstructured":"Fang D, Wan Y, Shen W, Cao J, Sun Z, Yu H, et al. Endoplasmic reticulum stress leads to lipid accumulation through upregulation of SREBP-1c in normal hepatic and hepatoma cells. Mol Cell Biochem. 2013;381:127\u201337.","journal-title":"Mol Cell Biochem"},{"key":"626_CR122","doi-asserted-by":"publisher","first-page":"1138078","DOI":"10.3389\/fendo.2023.1138078","volume":"14","author":"T Du","year":"2023","unstructured":"Du T, Xiang L, Zhang J, Yang C, Zhao W, Li J, et al. Vitamin D improves hepatic steatosis in NAFLD via regulation of fatty acid uptake and \u03b2-oxidation. Front Endocrinol. 2023;14:1138078.","journal-title":"Front Endocrinol"},{"key":"626_CR123","doi-asserted-by":"publisher","first-page":"e15347","DOI":"10.1016\/j.heliyon.2023.e15347","volume":"9","author":"MP Pathak","year":"2023","unstructured":"Pathak MP, Pathak K, Saikia R, Gogoi U, Patowary P, Chattopadhyay P, et al. Therapeutic potential of bioactive phytoconstituents found in fruits in the treatment of non-alcoholic fatty liver disease: A comprehensive review. Heliyon. 2023;9:e15347.","journal-title":"Heliyon"},{"key":"626_CR124","doi-asserted-by":"publisher","first-page":"6285","DOI":"10.3390\/ijms24076285","volume":"24","author":"Y Liu","year":"2023","unstructured":"Liu Y, Li D, Wang S, Peng Z, Tan Q, He Q, et al. 6-Gingerol Ameliorates Hepatic Steatosis, Inflammation and Oxidative Stress in High-Fat Diet-Fed Mice through Activating LKB1\/AMPK Signaling. Int J Mol Sci. 2023;24:6285.","journal-title":"Int J Mol Sci"},{"key":"626_CR125","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.fct.2018.09.011","volume":"121","author":"L Sharma","year":"2018","unstructured":"Sharma L, Lone NA, Knott RM, Hassan A, Abdullah T. Trigonelline prevents high cholesterol and high fat diet induced hepatic lipid accumulation and lipo-toxicity in C57BL\/6J mice, via restoration of hepatic autophagy. Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc. 2018;121:283\u201396.","journal-title":"Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc"},{"key":"626_CR126","doi-asserted-by":"publisher","first-page":"102231","DOI":"10.1016\/j.clinre.2023.102231","volume":"47","author":"P Tamilmani","year":"2023","unstructured":"Tamilmani P, Sathibabu Uddandrao VV, Chandrasekaran P, Saravanan G, Brahma Naidu P, Sengottuvelu S, et al. Linalool attenuates lipid accumulation and oxidative stress in metabolic dysfunction-associated steatotic liver disease via Sirt1\/Akt\/PPRA-\u03b1\/AMPK and Nrf-2\/HO-1 signaling pathways. Clin Res Hepatol Gastroenterol. 2023;47:102231.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"626_CR127","doi-asserted-by":"publisher","first-page":"109403","DOI":"10.1016\/j.jnutbio.2023.109403","volume":"119","author":"J Yang","year":"2023","unstructured":"Yang J, Zou J, Mai H, Hong T, Liu H, Feng D. Curcumin protects against high-fat diet-induced nonalcoholic simple fatty liver by inhibiting intestinal and hepatic NPC1L1 expression via down-regulation of SREBP-2\/HNF1\u03b1 pathway in hamsters. J Nutr Biochem. 2023;119:109403.","journal-title":"J Nutr Biochem"},{"key":"626_CR128","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1002\/mnfr.201600197","volume":"60","author":"R Kamikubo","year":"2016","unstructured":"Kamikubo R, Kai K, Tsuji-Naito K, Akagawa M. \u03b2-Caryophyllene attenuates palmitate-induced lipid accumulation through AMPK signaling by activating CB2 receptor in human HepG2 hepatocytes. Mol Nutr Food Res. 2016;60:2228\u201342.","journal-title":"Mol Nutr Food Res"},{"key":"626_CR129","first-page":"1156","volume":"26","author":"L Seidemann","year":"2021","unstructured":"Seidemann L, Kr\u00fcger A, Kegel-H\u00fcbner V, Seehofer D, Damm G. Influence of Genistein on Hepatic Lipid Metabolism in an In Vitro Model of Hepatic Steatosis. Mol Basel Switz. 2021;26:1156.","journal-title":"Mol Basel Switz"}],"container-title":["Current Obesity Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13679-025-00626-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13679-025-00626-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13679-025-00626-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T06:03:20Z","timestamp":1745993000000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13679-025-00626-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":129,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["626"],"URL":"https:\/\/doi.org\/10.1007\/s13679-025-00626-y","relation":{},"ISSN":["2162-4968"],"issn-type":[{"value":"2162-4968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"1 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised. The reference citation numbers in Phenolic, Terpenoid and Flavonoid rows at Table 4 were updated.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"This article does not contain any studies with human subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"36"}}